Genmab and AbbVie Announce Positive Topline Results from

Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage with global regulatory authorities...

Related Keywords

United States ,Japan ,Netherlands ,Denmark ,Copenhagen ,Køavn ,New Jersey ,Tokyo ,Marisol Peron ,Hematol Hemoter ,Kalvebod Brygge ,Andrew Carlsen ,European Union ,Ministry Of Health ,Corporate Affairs ,Lymphoma Research Foundation ,Abbvie Biotechnology Ltd ,Company Announcement ,Data From The Observational National Lymphocare Study ,Drug Administration ,Exchange Commission ,Us Inc ,European Medicines Agency ,Project Optimus ,Chief Executive Officer ,Follicular Lymphoma ,Marketing Authorization Application ,European Medicines ,Release Syndrome ,Senior Vice President ,Vice President ,Annual Report ,Y Shaped Genmab ,Abbvie Biotechnology ,Accessed June ,Expert Opin Med ,Rev Bras Hematol ,Subsequent Therapy ,Data From ,Observational National Lymphocare ,Treatment Patterns ,Patients With Diffuse Largeb Cell Lymphoma ,Copenhagen Stock Exchange Gen ,Genmaba S ,